Key facts
- · Type: Amendment first sale 2025-10-06 · Amount sold: $3.38M · Total offering: $3.50M · SEC filing
- · Type: New offering first sale 2025-10-06 · Amount sold: $2.92M · Total offering: $3M · SEC filing
- · Type: Filing · SEC filing
- · Type: Amendment · SEC filing
- · Type: Filing · SEC filing
Is Pacific Diabetes Technologies, Inc. a real, registered company?
Pacific Diabetes Technologies, Inc. is a registered filer with the SEC (CIK 1835476) and has filed since 2023-09-13. 5 filings are on record, the latest on 2025-11-17.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
How much has Pacific Diabetes Technologies, Inc. raised?
Its new offerings report $2.92M sold across 1 offering, as its own filings state.
Run the free check on Pacific Diabetes Technologies, Inc. →
PORTLAND, OREGON
2021
Biotechnology
5
$2.92M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2025-11-17 | Amendment first sale 2025-10-06 | $3.38M | $3.50M | SEC filing |
| 2025-10-20 | New offering first sale 2025-10-06 | $2.92M | $3M | SEC filing |
| 2025-03-14 | Filing | — | — | SEC filing |
| 2024-09-09 | Amendment | — | — | SEC filing |
| 2023-09-13 | Filing | — | — | SEC filing |
Keep reading
More on Pacific Diabetes Technologies, Inc. and the records around it.
Pacific Diabetes Technologies, Inc. elsewhere on the record
- Form D filing Oct 2025
- Form D filing Mar 2025
Watch Pacific Diabetes Technologies, Inc.
Get an email when Pacific Diabetes Technologies, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Pacific Diabetes Technologies, Inc.?
Who to contact
- Thomas Seidl — Executive Officer, Director, Promoter
- Hank Wuh — Director
- Christopher Marsh — Director
- Round: Form D/A (amended) filed 2025-11-17
- Amount sold: $3.38M
- Industry: Biotechnology
- Founded: 2021
- Based: PORTLAND, OREGON
People listed
- Thomas Seidl — Executive Officer, Director, Promoter
- Hank Wuh — Director
- Christopher Marsh — Director
- Filing: Form D/A (amended) filed 2025-11-17
- Amount sold: $3.38M
- Industry group: Biotechnology
- Year formed: 2021
- Based: PORTLAND, OREGON
- Entity type: Corporation
We'll show it in your MentionFox inbox when Pacific Diabetes Technologies, Inc. raises, hires or launches. No email unless you switch it on.
Watch Pacific Diabetes Technologies, Inc. →Want the whole picture on Pacific Diabetes Technologies, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Pacific Diabetes Technologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pacific Diabetes Technologies, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Pacific Diabetes Technologies, Inc.'s own filings with the SEC. The people those filings name are on the team page.